Aveo Pharmaceuticals, Inc.

MORGAN STANLEY

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/14/2023

Shares

515,099

Value ($000)

7,701

Weight

0.0%

2020 Q1 - 2022 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/14/2023	7,701	0.0%	515,099	12/31/2022
2022 Q3	11/14/2022	869	0.0%	105,475	9/30/2022
2022 Q2	10/27/2022	302	0.0%	46,043	6/30/2022
2022 Q1	10/27/2022	246	0.0%	44,140	3/31/2022
2021 Q4	2/14/2022	151	0.0%	32,088	12/31/2021
2021 Q3	11/15/2021	445	0.0%	71,916	9/30/2021
2021 Q2	8/23/2021	474	0.0%	71,855	6/30/2021
2021 Q1	5/17/2021	1,083	0.0%	148,032	3/31/2021
2020 Q4	2/16/2021	117	0.0%	20,266	12/31/2020
2020 Q3	11/13/2020	105	0.0%	17,619	9/30/2020
2020 Q2	8/14/2020	1,259	0.0%	244,411	6/30/2020
2020 Q1	5/26/2020	43	0.0%	12,008	3/31/2020